Amylin Pharmaceuticals Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | (19.5) | (125.2) | (126.0) |
| Net Investing Cash Flow | (182.2) | (296.1) | (425.9) |
| Net Financing Cash Flow | 16.7 | 776.9 | 546.5 |
| Net Change in Cash | (185.0) | 355.6 | (5.4) |
| Depreciation & Amortization | 33.3 | 21.6 | 16.2 |
| Capital Expenditures | (295.1) | (268.7) | (97.9) |
| Cash Dividends Paid | -- | -- | -- |
© 2009 Morningstar, Inc. Financial Data provided by
